Geneos Wealth Management’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,700
| Closed | -$30K | – | 2111 |
|
|
2022
Q2 | $30K | Sell |
1,700
-500
| -23% | -$8.82K | ﹤0.01% | 1491 |
|
|
2022
Q1 | $44K | Hold |
2,200
| – | – | ﹤0.01% | 1439 |
|
|
2021
Q4 | $41K | Hold |
2,200
| – | – | ﹤0.01% | 1556 |
|
|
2021
Q3 | $43K | Buy |
+2,200
| New | +$43K | ﹤0.01% | 1557 |
|
|
2020
Q4 | – | Sell |
-4,500
| Closed | -$83K | – | 2908 |
|
|
2020
Q3 | $83K | Hold |
4,500
| – | – | ﹤0.01% | 1026 |
|
|
2020
Q2 | $73K | Buy |
4,500
+1,800
| +67% | +$29.2K | ﹤0.01% | 1053 |
|
|
2020
Q1 | $44K | Hold |
2,700
| – | – | ﹤0.01% | 1167 |
|
|
2019
Q4 | $56K | Hold |
2,700
| – | – | ﹤0.01% | 1188 |
|
|
2019
Q3 | $30K | Hold |
2,700
| – | – | ﹤0.01% | 1418 |
|
|
2019
Q2 | $35K | Hold |
2,700
| – | – | ﹤0.01% | 1364 |
|
|
2019
Q1 | $40K | Sell |
2,700
-2,000
| -43% | -$29.6K | ﹤0.01% | 1242 |
|
|
2018
Q4 | $77K | Hold |
4,700
| – | – | 0.01% | 920 |
|
|
2018
Q3 | $69K | Buy |
+4,700
| New | +$69K | ﹤0.01% | 1027 |
|